Literature DB >> 709354

Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis.

D A Compston, J R Batchelor, C J Earl, W I McDonald.   

Abstract

One-hundred and forty-six patients who had presented with optic neuritis but without evidence of demyelination elsewhere in the nervous system, and in whom no specific cause could be identified, were reassessed clinically between one month and twenty-three years after the onset. Fifty-eight patients (40 per cent) had developed MS. All 146 patients were HLA-typed. Three factors were identified which were significantly associated with the development of MS: positive typing for the HLA antigen BT 101, winter onset of the initial attack of optic neuritis in BT 101-positive patients only, and recurrent attacks of optic neuritis. The application of these results to the individual patient is of limited use. However, recurrent attacks of optic neuritis should be given the same significance in the clinical classification of MS as episodes of demyelination occurring elsewhere in the central nervous system in a patient with a previous attack of optic neuritis. The results suggest that optic neuritis is caused by two different environmental agents or groups of agents and that the agent which is most common in the winter leads to the development of MS in the genetically susceptible individual. The agent more common in the summer is much less likely to cause MS in either suscetible or non-susceptible individuals. The biological role of the HLA system in the handling of foreign antigens is discussed and it is suggested that the presence of the HLA antigens associated with MS confers a specific disadvantage on individuals in the ability to handle infection by the MS causative agent and that this allows damaging immunological processes to develop.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709354     DOI: 10.1093/brain/101.3.495

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

Review 1.  Physicians, subsequence and consequence.

Authors:  W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 2.  The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system.

Authors:  W I McDonald; D Barnes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

3.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

4.  Papillitis and hepatitis B.

Authors:  C F Farthing; R S Howard; R N Thin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

5.  Optic neuritis, confirmed by visual evoked response, and the risk for multiple sclerosis: a prospective survey.

Authors:  E A Sanders; G H van Lith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

6.  Prognosis of optic neuritis.

Authors: 
Journal:  Br Med J       Date:  1979-03-24

Review 7.  Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy.

Authors:  J G Phadke; P V Best
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

8.  Multiple sclerosis following optic neuritis in Chile.

Authors:  G Alvarez; M Cárdenas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

9.  Acute optic neuritis: a prospective study of risk factors for multiple sclerosis.

Authors:  M A Hely; P G McManis; T J Doran; J C Walsh; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

10.  Optic neuropathy in sarcoidosis.

Authors:  E M Graham; C J Ellis; M D Sanders; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.